• Stock Chart

    Stock Chart

    Citius Pharmaceuticals, Inc.(CTXR)

    NASDAQ

    $0.9

    0.009(1.01%)

    CTXR Company Profile

    11 Commerce Drive

    Cranford, NJ 07016
    1.908.967.6677
    http://www.citiuspharma.com
    Sector: Health Technology
    Industry: Pharmaceuticals: Major
    Full Time Employees: 9

    Citius Pharmaceuticals, Inc. engages in the development and commercialization of therapeutic products. It offers Mino-Lok, a patented solution to treat and salvage infected central venous catheters in patients with catheter related bloodstream infections and Hydro-Lido, a topical formulation of hydrocortisone and lidocaine that is intended for treatment of hemorrhoids. The company was founded by Ralph Montrone on January 23, 2007 and is headquartered in Cranford, NJ.

    • Previous Close
      0.891
    • Open
      0.8925
    • Bid
      0
    • Ask
      0
    • Day's Range
      0.892 - 0.98
    • 52 week Range
      0.4 - 1.5
    • Volume
      5194426
    • Avg. Volume
      1855350
    • Market Cap
      40668210
    • Beta (5Y Monthly)
      0.8925
    • PE Ratio (TTM)
      -1.41
    • EPS (TTM)
      0
    • Earnings Date
      0.8925
    • Forward Dividend & Yield
      0.8925
    • Ex-Dividend Date
      5235495
    • 1y Target Est
      0.8925

    KEEP ME INFORMED ON CTXR UPDATES

    CTXR Performance

    • 5 Day
      2.4138%
    • 1 Month
      -2.0879%
    • 3 Month
      32.9851%
    • YTD
      -10.0908%
    • 1 Year
      -23.1897%

    CTXR on Twitter

    CTXR on iHub

    CTXR News

    /*
  • */